Tele-Epilepsy Market Growth at a CAGR of 13.97% from 2022 to 2030

According to Vision Research Report, the global tele-epilepsy market size was USD 0.37 billion in 2021 and is expected to reach USD 1.2 billion by 2030 and register a revenue CAGR of 13.97% during the forecast period, 2022-2030.

Report Highlights

The adult patient segment held the largest market share of 57.2% in 2021.
The pediatric segment is anticipated to expand at a CAGR of 15.63% during the forecast period.
The hardware component held the largest share of over 41.02% in 2021.
The service segment is anticipated to progress at a CAGR of 16.43% during the forecast period from 2022 to 2030.
The hospital segment accounted for a substantial revenue share of 34.23% in the market in 2021 and is expected to expand at a healthy CAGR of 15.76% during the forecast period.
North America dominated the market with a revenue share of 37.91% in 2021.
Asia Pacific is expected to expand at a CAGR of 16.77% during the assessment period.

Immediate Delivery Available | Get the sample copy of [email protected] https://www.visionresearchreports.com/report/sample/39874

The COVID-19 pandemic had a positive impact on the tele-epilepsy industry. The outbreak severely impacted the healthcare system and the economy, which created a special barrier for individuals seeking medical care, including epilepsy care. In addition, telehealth initiatives have demonstrated a high level of patient and physician satisfaction and quality during COVID-19. It has been seen that providing complex epilepsy care, including to patients with severity in epilepsy, could be solved, and can produce results that are comparable to those of in-person consultations.

Governments worldwide are initiating programs to uplift the market for tele-epilepsy. For instance, several government entities are embracing telehealth by implementing new regulations and reimbursement standards. In March 2020, The Federal Communications Commission in the US developed initiatives to aid healthcare organizations in implementing telemedicine technology.

Scope of The Report

Report Coverage	Details
Market Size in 2021	USD 0.37 billion
Revenue Forecast by 2030	USD 1.2 billion
Growth rate from 2022 to 2030	CAGR of 13.97%
Base Year	2021
Forecast Period	2022 to 2030
Segmentation	Patient, component, end-use, region
Companies Covered	Shimmer; Empatica; SOC Telemed; Eagle Telemedicine; Sevaro; Tele Specialists; Chiron Health; RTTC; Science Soft USA Corporation; Vidyo, Inc.

Patient Market Insights

The adult patient segment held the largest market share of 57.2% in 2021, as a result of an increase in the adult population considering the severity. An adult suffering from epilepsy is at more risk of getting into severe conditions after seizures, which increases the role of tele-epilepsy. Based on patients, the tele-epilepsy market is segmented into pediatric and adult segments.

The pediatric segment is anticipated to expand at a CAGR of 15.63% during the forecast period. Epilepsy cases in children are different from those in adults, in the context of seizure type and epilepsy syndrome, as children have higher immunity levels and are less prone to other diseases. For instance, juvenile convulsions and epileptic syndromes like Lennox-Gastaut disorder, childhood absence epilepsy, and Dravet syndrome are frequently distinct in the pediatric population.

Immediate Delivery Available | Buy this Premium Research [email protected] https://www.visionresearchreports.com/report/cart/39874

Component Insights

The hardware component held the largest share of over 41.02% in 2021, due to the extensive use of videoconferencing technology, audio equipment, microphones, and other medical accessories to support virtual visits. For instance, in March 2021, IVP Research Labs, Schlesinger Group, and Shimmer Research launched the official NeuroLynQ service process for central location studies. It offers a remote biometric tracking device that makes it possible to assess users' unconscious human emotions while they are home. Based on component, the market is segmented into hardware, service, and software.

The service segment is anticipated to progress at a CAGR of 16.43% during the forecast period from 2022 to 2030, owing to the growth of remote patient monitoring solutions. The segment growth will be fueled by the widespread usage of teleconsulting between patients and clinicians. For instance, in September 2019, Eagle Telemedicine announced the launch of TeleNocturnist and TeleHospitalist programs at the Jersey Community Hospital. This initiative will help expand the reach of the company’s services across rural locations in the U.S.

End-use Insights

The hospital segment accounted for a substantial revenue share of 34.23% in the market in 2021 and is expected to expand at a healthy CAGR of 15.76% during the forecast period. The growth is anticipated as hospitals are preferred by patients for their treatment process, in the context of convenience and variety of product offerings in one place. Moreover, hospitals are omnipresent and easily accessible to all patients. Based on end-use, the market is segmented into hospitals, payers, and healthcare consumers.

The healthcare consumer segment is poised to witness growth in the adoption of teleconsultation services because of the efficiency and effectiveness of online consultation, with the benefit of getting treatment in time of emergency from their place.

Regional Insights

North America dominated the market with a revenue share of 37.91% in 2021, owing to the technologically advanced infrastructure, rising number of epilepsy cases, and growing per capita income. In addition, presence of many market players and supporting government regulations in the region are boosting regional growth. For instance, in March 2020, The Federal Communications Commission in the U.S. developed initiatives to aid healthcare organizations in implementing telemedicine technology.

Asia Pacific is expected to expand at a CAGR of 16.77% during the assessment period, owing to the significant adoption of advanced technologies, enhanced network connectivity, rising incidence of epilepsy cases, and increased government program offerings.

For instance, in February 2022, the Myanmar WHO Program launched for Reducing the Epilepsy Treating Gap and the Psychiatric Gap Action Program succeeded in achieving these objectives. These initiatives aimed to improve the capacity of community-based primary care and non-specialist healthcare practitioners to identify, manage, and follow up on epilepsy patients. Due to the impact of these 4 pilot programs, 6.5 million people have received epilepsy treatment.

Related Reports